Global Pricing Management

International reference pricing (IRP), a lack of visibility into global markets, and siloed systems make optimizing and protecting prices difficult.

Mispricing and mismanaging prices globally can be costly.
Price erosion is inevitable with IRP, as 71% of countries rely on it solely for price decision-making.
Poor product launches and inaccurate market forecasts lead to multi-million-dollar mistakes.

Benefits of Model N Global Pricing Management

Decrease price erosion and optimize 100% of your product’s global revenue.

Improved margins

Make continuous adjustments to realize better prices throughout the product lifecycle.

Increased efficiency

Reduce risk of rogue pricing by implementing workflows and approval processes.

Greater visibility

Access accurate, detailed, and up-to-date pricing, reimbursement, and market access (PRMA) information from a single global repository.

Better decision-making

Access built-in analytics and dashboards to design and execute global market access strategies.

28%

Of a total market access budget is spent on the launch strategy.

Trusted by leading pharma innovators

Effectively execute pricing strategies

This cloud-based solution tracks and governs prices, optimizes launch sequences, simulates IRP events, and provides pricing insights.

IRP simulation

Proactively drive pricing policies by monitoring pricing and reimbursement events.

Price controls

Access a global pricing repository for prices, discounts, and reimbursements.

Global Launch Excellence

Create realistic launch sequences by combining accurate price data, volume forecasts, and optimization algorithms.

Support for loss of exclusivity events

Capture loss of exclusivity information at the country rules level, track competitors’ pricing, simulate pricing decisions, and calculate the impact on revenue.

Optimize and protect revenue throughout the commercialization process

Global Pricing Management is a core component of the Model N revenue optimization platform, purpose-built to give pharma companies complete control over their revenue and compliance processes.